Literature DB >> 18040511

Noninvasive monitoring of glucose concentration with optical coherence tomography.

R O Esenaliev, K V Larin, I V Larina, M Motamedi.   

Abstract

We have proposed a tested in tissue phantoms and in vivo a novel sensor based on optical coherence tomography (OCT) for noninvasive and continuous monitoring of blood glucose concentration. OCT images were obtained from pig and rabbit skin before and after glucose administration. Slopes of OCT signals decreased substantially (~40% in tissues in vivo) and linearly with the increase of blood glucose concentration from 4 to 30 mM, typical for normal and diabetic subjects. Phantom studies demonstrated 1% accuracy of scattering-coefficient measurement. Our theoretical and experimental studies suggest that glucose concentration can potentially be measured noninvasively with high sensitivity and accuracy with OCT systems.

Entities:  

Year:  2001        PMID: 18040511     DOI: 10.1364/ol.26.000992

Source DB:  PubMed          Journal:  Opt Lett        ISSN: 0146-9592            Impact factor:   3.776


  25 in total

1.  Quantitative tool for rapid disease mapping using optical coherence tomography images of azoxymethane-treated mouse colon.

Authors:  Amy M Winkler; Photini F S Rice; Rebekah A Drezek; Jennifer K Barton
Journal:  J Biomed Opt       Date:  2010 Jul-Aug       Impact factor: 3.170

2.  In vivo imaging of murine endocrine islets of Langerhans with extended-focus optical coherence microscopy.

Authors:  M Villiger; J Goulley; M Friedrich; A Grapin-Botton; P Meda; T Lasser; R A Leitgeb
Journal:  Diabetologia       Date:  2009-05-30       Impact factor: 10.122

3.  Iris as a reflector for differential absorption low-coherence interferometry to measure glucose level in the anterior chamber.

Authors:  Yong Zhou; Nan Zeng; Yanhong Ji; Yao Li; Xiangsong Dai; Peng Li; Lian Duan; Hui Ma; Yonghong He
Journal:  J Biomed Opt       Date:  2011 Jan-Feb       Impact factor: 3.170

4.  Prediction capability of optical coherence tomography for blood glucose concentration monitoring.

Authors:  Roman V Kuranov; Veronika V Sapozhnikova; Donald S Prough; Inga Cicenaite; Rinat O Esenaliev
Journal:  J Diabetes Sci Technol       Date:  2007-07

5.  Continuous noninvasive monitoring of changes in human skin optical properties during oral intake of different sugars with optical coherence tomography.

Authors:  Yuqing Zhang; Guoyong Wu; Huajiang Wei; Zhouyi Guo; Hongqin Yang; Yonghong He; Shusen Xie; Ying Liu
Journal:  Biomed Opt Express       Date:  2014-02-28       Impact factor: 3.732

6.  Measurements of the thermal coefficient of optical attenuation at different depth regions of in vivo human skins using optical coherence tomography: a pilot study.

Authors:  Ya Su; X Steve Yao; Zhihong Li; Zhuo Meng; Tiegen Liu; Longzhi Wang
Journal:  Biomed Opt Express       Date:  2015-01-12       Impact factor: 3.732

7.  Analysis of attenuation coefficient estimation in Fourier-domain OCT of semi-infinite media.

Authors:  Babak Ghafaryasl; Koenraad A Vermeer; Jeroen Kalkman; Tom Callewaert; Johannes F de Boer; Lucas J Van Vliet
Journal:  Biomed Opt Express       Date:  2020-10-06       Impact factor: 3.732

8.  Determination of confocal profile and curved focal plane for OCT mapping of the attenuation coefficient.

Authors:  Sabina Stefan; Ki-Soo Jeong; Collin Polucha; Nikos Tapinos; Steven A Toms; Jonghwan Lee
Journal:  Biomed Opt Express       Date:  2018-10-01       Impact factor: 3.732

9.  Effect of temperature on permeation of low-density lipoprotein particles through human carotid artery tissues.

Authors:  Mohamad G Ghosn; Michael Leba; Astha Vijayananda; Panteha Rezaee; Joel D Morrisett; Kirill V Larin
Journal:  J Biophotonics       Date:  2009-10       Impact factor: 3.207

10.  Depth-resolved imaging and detection of micro-retroreflectors within biological tissue using Optical Coherence Tomography.

Authors:  Steven N Ivers; Stephan A Baranov; Tim Sherlock; Katerina Kourentzi; Paul Ruchhoeft; Richard Willson; Kirill V Larin
Journal:  Biomed Opt Express       Date:  2010-08-02       Impact factor: 3.732

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.